Bone Mineral Density News and Research

RSS

Researchers discover gene locations affecting wrist bones in children

Pediatric researchers have discovered gene locations affecting bone strength in wrist bones, the most common site for fractures in children. Children who have those genetic variants may be at higher-than-average risk of wrist fractures, and could especially benefit from activities and diets that promote bone strength.

30 Jun 2015

Scientists identify association between coronary heart disease and osteoporosis

University of Southampton scientists have discovered a link between coronary heart disease and osteoporosis, suggesting both conditions could have similar causes.

29 Jun 2015

Aeterna Zentaris selects Ergomed to manage Phase 3 clinical study of Macrilen

Aeterna Zentaris Inc. announced today that it has executed a definitive agreement with Ergomed PLC, pursuant to which Ergomed will manage the new, confirmatory Phase 3 clinical study to demonstrate the efficacy of Macrilen (macimorelin), a novel orally-active ghrelin agonist for use in evaluating adult growth hormone deficiency ("AGHD").

25 Jun 2015

Study suggests that dried plums may help support healthy bones

The International Symposium on Nutritional Aspects of Osteoporosis brings together the best scientific minds in bone health research and nutrition. Current research presented at the 2015 Ninth ISNAO has added to the increasing body of evidence that suggests dried plums (prunes) help to support healthy bones and may even promote attainment of peak bone mass.

18 Jun 2015

Recurrent major depression may increase osteoporosis risk in men

A recent study from the University of Eastern Finland in collaboration with Deakin University, Australia, shows that recurrent major depressive disorder (MDD) in men is associated with lower bone density. The use of antidepressants was also associated with lower bone mineral density (BMD), but this association was dependent on the person's weight and site of bone measurement.

12 Jun 2015

Neurocrine reports net loss of $1.2 million for first quarter 2015

Neurocrine Biosciences, Inc. today announced its financial results for the quarter ended March 31, 2015. For the first quarter of 2015, the Company reported a net loss of $1.2 million, or $0.01 loss per share, compared to a net loss of $11.8 million, or $0.17 loss per share, for the same period in 2014.

30 Apr 2015

Scientists find link between higher muscle mass and healthier bone development in children

Scientists at the University of Southampton have shown that higher muscle mass is strongly linked with healthier bone development in children.

15 Apr 2015

Aeterna Zentaris plans to conduct Macrilen Phase 3 clinical study for AGHD

Aeterna Zentaris Inc. today announced plans to conduct a new, confirmatory Phase 3 clinical study to demonstrate the efficacy of Macrilen (macimorelin), a novel orally-active ghrelin agonist for use in evaluating adult growth hormone deficiency ("AGHD"), as well as a dedicated thorough QT study to evaluate the effect of Macrilen on myocardial repolarization.

13 Apr 2015

Investigational S-equol nutritional supplement may alleviate certain menopause symptoms

The investigational S-equol nutritional supplement may be a viable agent to alleviate certain menopause symptoms, such as hot flashes, according to a new peer-reviewed article in the March Journal of Women's Health.

30 Mar 2015

New study shows positive effects of gastric bypass surgery on obese adolescents

The skeletons of obese adolescents are usually more dense than those of normal weight teens, but after gastric bypass surgery, most return to normal density within two years, a new study finds.

9 Mar 2015

$Investigational drug for postmenopausal osteoporosis reduces rate of new spinal fractures$

Investigational drug for postmenopausal osteoporosis reduces rate of new spinal fractures

Abaloparatide-SC, an injectable drug being studied for the treatment of postmenopausal osteoporosis, reduces the rate of new spinal fractures by a statistically significant 86 percent and as well as statistically significant reductions in the fracture rate at other parts of the body, a phase 3 clinical trial finds. Results of the ACTIVE fracture prevention trial will be described in a late-breaking oral presentation Thursday at the Endocrine Society's 97th annual meeting in San Diego.

9 Mar 2015

Adult survivors of childhood cancer at risk for pituitary hormone deficiencies

Decades after undergoing cranial irradiation for childhood cancer, St. Jude Children's Research Hospital investigators found that adult survivors of pediatric cancer remain at risk for pituitary hormone deficiencies that may diminish their health and quality of life.

16 Feb 2015

Tenofovir stems treatment-induced kidney toxicity in HBV-related chronic hepatitis

Switching to tenofovir may stave further kidney and bone impairment in patients with hepatitis B virus-related chronic hepatitis taking adefovir-based therapy, retrospective study findings suggest.

28 Jan 2015

Study finds no evidence that testosterone replacement therapy increases cardiovascular risk

Fears of a link between testosterone replacement therapy and cardiovascular risk are misplaced, according to a review published in this month's Mayo Clinic Proceedings. The therapy has come under widespread scrutiny in recent months, including by a federal Food and Drug Administration panel convened last fall.

28 Jan 2015

Study finds relationship between menopausal symptoms, bone health in postmenopausal women

The first large prospective cohort study to examine the relationship between menopausal symptoms and bone health in postmenopausal women has found that those who experience moderate to severe hot flashes and night sweats during menopause tend to have lower bone mineral density and higher rates of hip fracture than peers with no menopausal symptoms.

23 Jan 2015

Bone Mineral Density News and Research

Researchers discover gene locations affecting wrist bones in children

Scientists identify association between coronary heart disease and osteoporosis

Aeterna Zentaris selects Ergomed to manage Phase 3 clinical study of Macrilen

Study suggests that dried plums may help support healthy bones

Recurrent major depression may increase osteoporosis risk in men

Neurocrine reports net loss of $1.2 million for first quarter 2015

Scientists find link between higher muscle mass and healthier bone development in children

Aeterna Zentaris plans to conduct Macrilen Phase 3 clinical study for AGHD

Investigational S-equol nutritional supplement may alleviate certain menopause symptoms

New study shows positive effects of gastric bypass surgery on obese adolescents

Investigational drug for postmenopausal osteoporosis reduces rate of new spinal fractures

Adult survivors of childhood cancer at risk for pituitary hormone deficiencies

Tenofovir stems treatment-induced kidney toxicity in HBV-related chronic hepatitis

Study finds no evidence that testosterone replacement therapy increases cardiovascular risk

Study finds relationship between menopausal symptoms, bone health in postmenopausal women

Life satisfaction associated with higher bone density in older women

Study measures effects of high-fat maternal diet on the cognitive functioning of offspring

Dietary supplement KoACT is superior to calcium, vitamin D for bone health, study reveals

IOF data shows 93% of US adults are unaware of men’s susceptibility to osteoporosis

The Female Athlete Triad: A medical condition in active girls and women

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News